€ 47.64
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Very weak growth
About
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral o
Target Price
The average target price of FRE.DE is 49 and suggests 4% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation s
